• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

RECALL: Nexterone Recalled Due to Particulate Matter

November 18, 2017
Kerry Lengyel

Baxter International has voluntarily recalled 1 lot of the antiarrhythmic Nexterone (amiodarone) due to the potential presence of particulate matter.

Baxter International Inc., a Fortune 500 health care company, is voluntarily recalling 1 lot of Nexterone (amiodarone HCl) 150 mg/100 mL Premixed Injection due to the potential presence of particulate matter. This lot was distributed to US wholesalers, distributors, and health care facilities between June 23, 2017 and October 2, 2017.

After performing a stability study, Baxter identified the particulate matter in a single lot to be consistent with polyethylene, which is the primary constituent of the film and ports used to manufacture the bag in which the medication is packaged.

If the medical practitioner does not use inline filtration, these particles could cause local vein irritation, inflammatory reaction, aggravation of preexisting infections, allergic reactions, phlebitis, pulmonary emboli, pulmonary granulomas, and systemic embolization.

According to the FDA, “Nexterone is a prescription antiarrhythmic agent indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.”

If administered intravenously, this contaminated solution could lead to adverse health consequences depending on the size, number and composition of the foreign material as well as the patient’s underlying medical condition.

The recall affects the lot of Nexterone with these qualities:

Advertisement

Product Code

Product Description

Lot Number

Expiration Date

NDC

2G3451

NEXTERONE (amiodarone HCl) Premixed Injection, 150 mg/100 mL

NC109925

6/1/2019

43066-150-10

According to Baxter, there have been no reports of adverse events associated with this recalled lot. The company urges practitioners to stop use and distribution and quarantine the recalled product immediately.

The recalled product may be returned to Baxter for credit by calling the company’s health care center for service at 888-229-0001.


Advertisement

Latest News

Pet Advocacy Network honors outstanding contributions to the pet care community

Traditional and holistic treatments for giardia

ASU trustees approve the creation of a new veterinary school

6 tips for first-time dog owners

View More Latest News
Advertisement